Effect of carrageenan food supplement on patients with cardiovascular disease results in normalization of lipid profile and moderate modulation of immunity system markers

PharmaNutrition

Volumn 2, Issue 2, 2014, Pages 33-37

  Sokolova, E V ^a   Bogdanovich, L N ^b   Ivanova, T B ^b   Byankina, A O ^a   Kryzhanovskiy, S P ^b   Yermak, I M ^a  

^a PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF BIOLOGY AND SOIL SCIENCE   (Russian Federation)

Author keywords

Carrageenan; Cholesterol; Food fibre; Immunity; Inflammation; Lipoprotein

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARRAGEENAN; CARRAGEENAN DV; CD16 ANTIGEN; CD22 ANTIGEN; FAS ANTIGEN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROTIC INDEX; BODY MASS; CARDIOVASCULAR PARAMETERS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIC ACTIVITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPHENOTYPING; ISCHEMIC HEART DISEASE; LEUKOCYTE; LIPID ANALYSIS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 84897902808     PISSN: 22134344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phanu.2014.02.001     Document Type: Article

References (34)

1. Veldhoen M, Brucklacher-Waldert V Dietary influences on intestinal immunity. Nature Reviews. Immunology 2012, 12:696-708. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nri3299.
2. Brownlee I.A. The physiological roles of dietary fibre. Food Hydrocolloids 2011, 25:238-250. 10.1016/j.foodhyd.2009.11.013.
3. Shimotoyodome A., Meguro S., Hase T., Tokimitsu I., Sakata T. Sulfated polysaccharides, but not cellulose, increase colonic mucus in rats with loperamide-induced constipation. Digestive Diseases and Sciences 2001, 46:1482-1489. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1023/a:1010644021888.
4. Estruch R., Martínez-González M.A., Corella D., Basora-Gallisá J., Ruiz-Gutiérrez V., Covas M.I., et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. Journal of Epidemiology and Community Health 2009, 63:582-588. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1136/jech.2008.082214.
5. Brown L., Rosner B., Willett W.W., Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. American Journal of Clinical Nutrition 1999, 69:30-42. http://www.ncbi.nlm.nih.gov/pubmed/.
6. Castro I.A., Barroso L.P., Sinnecker P. Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach. American Journal of Clinical Nutrition 2005, 82:32-40. http://www.ncbi.nlm.nih.gov/pubmed/.
7. Butt M.S., Shahzadi N., Sharif M.K., Nasir M. Guar gum: a miracle therapy for hypercholesterolemia, hyperglycemia and obesity. Critical Reviews in Food Science and Nutrition 2007, 47:389-396. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1080/10408390600846267.
8. Galisteo M., Duarte J., Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. Journal of Nutritional Biochemistry 2008, 19:71-84. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.jnutbio.2007.02.009.
9. Cencic A., Chingwaru W. The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients 2010, 2:611-625. http://www.ncbi.nlm.nih.gov/pubmed/, 10.3390/nu2060611.
10. Mohamed S., Hashim S.N., Rahman H.A. Seaweeds: a sustainable functional food for complementary and alternative therapy. Trends in Food Science & Technology 2012, 23:83-96. 10.1016/j.tifs.2011.09.001.
11. Joint FAO/WHO expert committee on food additives compendium of food additives specifications, Addendum 9: FAO Food and Nutrition Paper. 2001;52:192-4.
12. Joint FAO/WHO expert committee on food additives. Addendum 10. FAO Food and Nutrition Pipe, Compendium of food additives specifications. 2008;59:65-85.
13. Holdt S.L., Kraan S. Bioactive compounds in seaweed: functional food applications and legislation. Journal of Applied Phycology 2011, 23:543-597. 10.1007/s10811-010-9632-5.
14. Campo V.L., Kawano D.F., Silva D.B.D., Carvalho I. Carrageenans: biological properties, chemical modifications and structural analysis-a review. Carbohydrate Polymers 2009, 77:167-180. 10.1016/j.carbpol.2009.01.020.
15. Silva T.H., Alves A., Popa E.G., Reys L.L., Gomes M.E., Sousa R.A., et al. Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches. Biomatter 2012, 2:278-289. 10.4161/biom.22947.
16. Yermak I.M., Barabanova A.O., Aminin D.L., Davydova V.N., Sokolova E.V., Solov'eva T.F., et al. Effects of structural peculiarities of carrageenans on their immunomodulatory and anticoagulant activities. Carbohydrate Polymers 2012, 87:713-720. 10.1016/j.carbpol.2011.08.053.
17. Panlasigui L.N., Baello O.Q., Dimatangal J.M., Dumelod B.D. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pacific Journal of Clinical Nutrition 2003, 12:209-214.
18. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA: The Journal of the American Medical Association 2013, 310:2191. World Medical Association. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1001/jama.2013.281053.
19. Meissner K., Kohls N., Colloca L. Introduction to placebo effects in medicine: mechanisms and clinical implications. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2011, 366:1783-1789. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1098/rstb.2010.0414.
20. Bienenfeld L., Frishman W., Glasser S.P. The placebo effect in cardiovascular disease. American Heart Journal 1996, 132:1207-1221. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/s0002-8703(96)90465-2.
21. Belokrinizkyi D.V., Menshikov V.V. Methods of clinical immunology/Laboratory methods of research in clinic 1987, 277-311. Medicine: m{cyrillic}oscow.
22. Peters V.K. On R.A. Rutberg's method of fibrin determination. Laboratornoe Delo 1966, 7:393-396. http://www.ncbi.nlm.nih.gov/pubmed/.
23. Basu A., Devaraj S., Jialal I. Dietary factors that promote or retard inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:995-1001. 10.1161/01.atv.0000214295.86079.d1.
24. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. Journal of Clinical investigation 2005, 115:1111-1119. 10.1172/jci25102.
25. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 2008, 54:24-38. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1373/clinchem.2007.097360.
26. Anderson J.W., Baird P., Davis R.H., Ferreri S., Knudtson M., Koraym A., et al. Health benefits of dietary fiber. Nutrition Reviews 2009, 67:188-205. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1111/j.1753-4887.2009.00189.x.
27. Matanjun P., Mohamed S., Muhammad K., Mustapha N.M. Comparison of cardiovascular protective effects of tropical seaweeds, Kappaphycus alvarezii, Caulerpa lentillifera, and Sargassum polycystum, on high-cholesterol/high-fat diet in rats. Journal of Medicinal Food 2010, 13:792-800. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/jmf.2008.1212.
28. Guardamagna O., Abello F., Cagliero P., Visioli F. Could dyslipidemic children benefit from glucomannan intake?. Nutrition (Burbank, Los Angeles County, CA) 2013, 29:1060-1065. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.nut.2013.02.010.
29. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004, 84:1381-1478. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1152/physrev.00047.2003.
30. King D.E. Dietary fiber, inflammation, and cardiovascular disease. Molecular Nutrition & Food Research 2005, 49:594-600. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/mnfr.200400112.
31. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González Á., Esquivel-Chirino C., et al. Inflammation, oxidative stress, and obesity. International Journal of Molecular Sciences 2011, 12:3117-3132. http://www.ncbi.nlm.nih.gov/pubmed/, 10.3390/ijms12053117.
32. McIntosh M., Miller C. A diet containing food rich in soluble and insoluble fiber improves glycemic control and reduces hyperlipidemia among patients with type 2 diabetes mellitus. Nutrition Reviews 2001, 59:52-55. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1111/j.1753-4887.2001.tb06976.x.
33. Mayakrishnan V., Kannappan P., Abdullah N., Ahmed A.B.A. Cardioprotective activity of polysaccharides derived from marine algae: an overview. Trends in Food Science and Technology 2013, 30:98-104. 10.1016/j.tifs.2013.01.007.
34. -/- mice. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 2011, 64:36-43. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.phrs.2011.02.008.